Affibody AB
- Biotech or pharma, therapeutic R&D
Affibody is a clinical stage integrated biopharmaceutical company with a broad product pipeline focused on developing innovative next generation biopharmaceutical drugs in radiopharma and immunology based on its unique proprietary technology platform, Affibody® molecules.
Through its validated business model, the company has a proven capability of identifying and prioritizing strategic projects in a timely and de-risked way. Affibody has established several partnerships for the development and commercialization of its innovations with international pharmaceutical companies.
Affibody’s main shareholder Patricia Industries is a part of Investor AB.
Further information can be found at: www.affibody.com.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}